drugset

drugset / Trial / NCT05962424

HNC: Human Neural Circuits Electrophysiology During Cognition

NCT05962424 ↗

Phase 1 Recruiting 120 enrolled Stanford University

NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Timeline

Start: 2023-10-05
Primary completion: 2030-09-01
Completion: 2030-09-01

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ketamine	Small molecule	0.5 mg/kg	—

Indications